Valproic Acid
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Prescription mood stabilizer and anticonvulsant approved for bipolar mania, epilepsy (multiple seizure types), and migraine prophylaxis. Effective for acute mania and mixed episodes. Carries significant risks including hepatotoxicity, teratogenicity (neural tube defects), pancreatitis, and thrombocytopenia. Contraindicated in pregnancy for psychiatric indications due to high teratogenic risk. Requires serum level monitoring (target 50–125 mcg/mL). Dosage must be determined by your prescribing physician.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Prescription mood stabilizer and anticonvulsant approved for bipolar mania, epilepsy (multiple seizure types), and migraine prophylaxis. NutriStack rates the supporting evidence as strong. Common adult dosing is 500–3000 mg daily in divided doses; titrated to serum levels of 50–125 mcg/mL (as prescribed by your physician), though a prescriber sets the actual dose. With long-term use it can deplete carnitine, folate, vitamin d. This profile indexes 10 sources.
The bottom line
Evidence rating strong. Most-documented uses: acute mania treatment, seizure control across multiple types, migraine prophylaxis. 10 sources indexed (2020–2025), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Multiple mechanisms: increases GABA levels through inhibition of GABA transaminase and enhanced GABA synthesis; blocks voltage-gated sodium channels, reducing repetitive neuronal firing; modulates T-type calcium channels; and inhibits histone deacetylase (HDAC), which may contribute to neuroprotective and mood-stabilizing effects.
Dosing & protocol.
Take with food to reduce GI upset. Delayed-release and extended-release tablets should be swallowed whole. Sprinkle capsules may be opened and sprinkled on soft food.
What it depletes.
Nutrients this medication can lower over time, and what to replace.
Carnitine
SignificantValproate increases urinary carnitine loss and forms valproylcarnitine, which can deplete carnitine stores and impair mitochondrial beta-oxidation.
Folate
ModerateValproate is associated with lower folate status and altered one-carbon metabolism during chronic therapy.
Vitamin D
ModerateChronic valproate use is associated with lower vitamin D status and impaired bone health.
Calcium
ModerateLong-term valproate therapy is associated with lower bone mineral density and poorer calcium balance.
Biotin
MildValproate therapy may lower biotin status in susceptible users.
Full safety detail.
Side effects
- Nausea and GI upset
- Weight gain
- Tremor
- Hair loss
- Drowsiness
- Thrombocytopenia
- Elevated liver enzymes
- Polycystic ovary syndrome features
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
6- 1Valproate-Induced Model of Autism in Adult Zebrafish: A Systematic ReviewPMIDCamussi D, Marchese M, Nicoletti F et al. · Cells · 2025
Camussi D, Marchese M, Nicoletti F et al.. Valproate-Induced Model of Autism in Adult Zebrafish: A Systematic Review. Cells. 2025
- 2Subcutaneous sodium valproate in palliative care: A systematic reviewPMIDTan S, Ng JS, Tang C et al. · Palliative medicine · 2024
Tan S, Ng JS, Tang C et al.. Subcutaneous sodium valproate in palliative care: A systematic review. Palliative medicine. 2024
- 3Anatomical, behavioral, and cognitive teratogenicity associated with valproic acid: a systematic reviewPMIDValentino K, Teopiz KM, Kwan ATH et al. · CNS spectrums · 2024
Valentino K, Teopiz KM, Kwan ATH et al.. Anatomical, behavioral, and cognitive teratogenicity associated with valproic acid: a systematic review. CNS spectrums. 2024
- 4Valproic Acid-Associated Hyperammonemia: A Systematic ReviewPMIDWong YJ, Fan J, Wan A et al. · Journal of clinical psychopharmacology · 2023
Wong YJ, Fan J, Wan A et al.. Valproic Acid-Associated Hyperammonemia: A Systematic Review. Journal of clinical psychopharmacology. 2023
- 5Intravenous sodium valproate in status epilepticus: review and Meta-analysisPMIDLiampas I, Siokas V, Brotis A et al. · The International journal of neuroscience · 2021
Liampas I, Siokas V, Brotis A et al.. Intravenous sodium valproate in status epilepticus: review and Meta-analysis. The International journal of neuroscience. 2021
- 6A Systematic Review of the Valproic-Acid-Induced Rodent Model of AutismPMIDChaliha D, Albrecht M, Vaccarezza M et al. · Developmental neuroscience · 2020
Chaliha D, Albrecht M, Vaccarezza M et al.. A Systematic Review of the Valproic-Acid-Induced Rodent Model of Autism. Developmental neuroscience. 2020
Reference material
4- 7Geddes JR et al. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis. Am J Psychiatry. 2004.Source linkedPMID
- 8Bowden CL et al. A randomized, placebo-controlled trial of divalproex sodium in the treatment of acute mania. JAMA. 1994.Source linkedPMID
- 9Meador KJ et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study). Lancet Neurol. 2013.Source linkedPMID
- 10Valproic Acid. 2006Source linkedPMID
Common questions.
Quick answers about Valproic Acid, drawn from the data on this page.
What is Valproic Acid?
Prescription mood stabilizer and anticonvulsant approved for bipolar mania, epilepsy (multiple seizure types), and migraine prophylaxis. Effective for acute mania and mixed episodes. Carries significant risks including hepatotoxicity, teratogenicity (neural tube defects), pancreatitis, and thrombocytopenia. Contraindicated in pregnancy for psychiatric indications due to high teratogenic risk. Requires serum level monitoring (target 50–125 mcg/mL). Dosage must be determined by your prescribing physician.
What is Valproic Acid used for?
Commonly cited benefits of Valproic Acid include: Acute mania treatment; Seizure control across multiple types; Migraine prophylaxis; Mood stabilization; Rapid-cycling bipolar management. NutriStack rates the overall evidence as strong.
What is a typical dose of Valproic Acid?
A typical adult dose of Valproic Acid is 500–3000 mg daily in divided doses; titrated to serum levels of 50–125 mcg/mL (as prescribed by your physician). The commonly recommended form is Delayed-release tablet, extended-release tablet, capsule, or oral solution. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Valproic Acid?
Reported side effects include nausea and gi upset, weight gain, tremor, hair loss, drowsiness, thrombocytopenia. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Valproic Acid?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Valproic Acid in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.